Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) Director Tommy G. Thompson purchased 5,777 shares of the business's stock in a transaction on Wednesday, May 28th. The stock was purchased at an average cost of $17.27 per share, with a total value of $99,768.79. Following the acquisition, the director now owns 144,290 shares in the company, valued at approximately $2,491,888.30. This represents a 4.17% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Healthpeak Properties Price Performance
NYSE:DOC traded down $0.11 on Friday, reaching $17.41. The stock had a trading volume of 9,932,437 shares, compared to its average volume of 5,129,080. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The company has a market capitalization of $12.10 billion, a P/E ratio of 49.74, a price-to-earnings-growth ratio of 2.17 and a beta of 1.05. Healthpeak Properties, Inc. has a 1-year low of $16.64 and a 1-year high of $23.26. The stock has a fifty day moving average price of $18.16 and a 200-day moving average price of $19.71.
Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.46. The company had revenue of $702.89 million during the quarter, compared to analysts' expectations of $690.76 million. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. Healthpeak Properties's quarterly revenue was up 15.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.45 earnings per share. Research analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.
Healthpeak Properties Dividend Announcement
The firm also recently disclosed a dividend, which was paid on Friday, May 30th. Shareholders of record on Tuesday, May 20th were given a $0.1017 dividend. The ex-dividend date was Monday, May 19th. This represents a yield of 7.05%. Healthpeak Properties's payout ratio is 305.00%.
Hedge Funds Weigh In On Healthpeak Properties
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Barclays PLC bought a new position in shares of Healthpeak Properties in the third quarter valued at about $35,078,000. JPMorgan Chase & Co. increased its position in Healthpeak Properties by 23.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock valued at $493,115,000 after acquiring an additional 4,056,931 shares in the last quarter. Exchange Traded Concepts LLC raised its stake in shares of Healthpeak Properties by 10.0% in the fourth quarter. Exchange Traded Concepts LLC now owns 6,560 shares of the real estate investment trust's stock worth $133,000 after acquiring an additional 598 shares during the last quarter. Blue Trust Inc. lifted its position in shares of Healthpeak Properties by 27.1% during the fourth quarter. Blue Trust Inc. now owns 14,006 shares of the real estate investment trust's stock worth $284,000 after purchasing an additional 2,990 shares in the last quarter. Finally, Pacer Advisors Inc. lifted its position in shares of Healthpeak Properties by 12.4% during the fourth quarter. Pacer Advisors Inc. now owns 59,305 shares of the real estate investment trust's stock worth $1,202,000 after purchasing an additional 6,541 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have weighed in on DOC shares. Argus reiterated a "buy" rating and set a $25.00 price target on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Wall Street Zen lowered shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Thursday, May 1st. Robert W. Baird dropped their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. Wedbush cut their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Finally, Scotiabank decreased their price objective on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating on the stock in a report on Monday, May 12th. One research analyst has rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties presently has a consensus rating of "Moderate Buy" and a consensus target price of $23.45.
Check Out Our Latest Report on Healthpeak Properties
Healthpeak Properties Company Profile
(
Get Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Recommended Stories
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
